Anzeige
Mehr »
Dienstag, 21.07.2026 - Börsentäglich über 12.000 News
+50% in 13 Tagen - Steht der große Ausbruch jetzt bevor?
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A1JWL4 | ISIN: NO0010598683 | Ticker-Symbol: HBQ
Stuttgart
21.07.26 | 13:02
0,111 Euro
+11,00 % +0,011
1-Jahres-Chart
HOFSETH BIOCARE ASA Chart 1 Jahr
5-Tage-Chart
HOFSETH BIOCARE ASA 5-Tage-Chart
RealtimeGeldBriefZeit
0,1200,13213:22

Aktuelle News zur HOFSETH BIOCARE Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
09.07.HOFSETH BIOCARE ASA: NOTICE OF EXTRAORDINARY GENERAL MEETING3
07.07.HOFSETH BIOCARE ASA: MAJOR SHAREHOLDER NOTIFICATION1
03.07.HOFSETH BIOCARE ASA: NEW SHARE CAPITAL REGISTERED1
30.06.HOFSETH BIOCARE ASA: ANNUAL GENERAL MEETING COMPLETED-
30.06.HOFSETH BIOCARE ASA: FIRST QUARTER 2026 FINANCIAL REPORT AND NEW COMMERCIAL UPDATE FOR CURRENT TRADING1
29.06.HOFSETH BIOCARE ASA: MANDATORY NOTIFICATION OF TRADE-
29.06.HOFSETH BIOCARE ASA - VOTING UNDERTAKINGS SECURED IN RELATION TO PRIVATE PLACEMENT AND B-SHARE AMENDMENTS1
HOFSETH BIOCARE Aktie jetzt für 0€ handeln
29.06.HOFSETH BIOCARE ASA: DISCLOSURES OF LARGE SHAREHOLDINGS3
26.06.HOFSETH BIOCARE ASA: CONTEMPLATED PRIVATE PLACEMENT3
09.06.Hofseth Biocare ASA: NOTICE OF ANNUAL GENERAL MEETING 20262
28.05.Hofseth BioCare ASA: Financial calendar1
22.05.Hofseth BioCare ASA: EXCLUSIVE LICENSE AND SUPPLY AGREEMENT SIGNED FOR PROGO FOR OVER $5M161Hofseth BioCare ASA ("HBC") has entered into an Exclusive License and Supply Agreement (the "Agreement") with Fission Holdings LLC ("Fission"), a US-based affiliate and sales channel operator headquartered...
► Artikel lesen
14.04.Hofseth BioCare ASA: HBC publishes paradigm-changing clinical trial results of OmeGo full spectrum omegas304HBC announces the publication of its head-to-head clinical trial results with its patented, full spectrum omegas brand, OmeGo®. The trial showed that OmeGo® increased the Omega 3 Index (O3I) by over...
► Artikel lesen
27.03.Hofseth BioCare ASA: HBC ANNUAL REPORT 20251
13.02.Hofseth BioCare ASA: FOURTH QUARTER 2025 FINANCIAL REPORT779HBC recorded total operating revenues of NOK 72.2 million in the fourth quarter of 2025, compared to NOK 64.9 million in the same period last year. Net operating revenues were NOK 71.1 million, up...
► Artikel lesen
11.02.Hofseth Biocare ASA: Notification of major shareholdings2
07.11.25Hofseth Biocare ASA: Third Quarter 2025 Financial Report312HBC recorded total operating revenues of NOK 54.9 million in the third quarter of 2025, compared to NOK 67.9 million in the same period last year. Net operating revenues were NOK 54.8 million, reflecting...
► Artikel lesen
28.10.25XFRA CAPITAL ADJUSTMENT INFORMATION - 28.10.2025438Das Instrument 5YW CA07135M2031 BATTERY X METALS INC. EQUITY wird ex Kapitalmassnahme gehandelt am 28.10.2025 The instrument 5YW CA07135M2031 BATTERY X METALS INC. EQUITY is traded ex capital adjustment...
► Artikel lesen
24.10.25Hofseth Biocare ASA: USD 5 Million Divestment in Aecorbio306NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART DIRECTLY OR INDIRECTLY, IN AUSTRALIA, CANADA, JAPAN OR THE UNITED STATES OR ANOTHER JURISDICTION IN WHICH THE RELEASE, PUBLICATION...
► Artikel lesen
24.10.25Hofseth BioCare ASA: Contemplated Private Placement and Partial Divestment of Shares in Aecorbio484NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART DIRECTLY OR INDIRECTLY, IN AUSTRALIA, CANADA, JAPAN OR THE UNITED STATES OR ANOTHER JURISDICTION IN WHICH THE RELEASE, PUBLICATION...
► Artikel lesen
Weiter >>
22 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1